SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-04-000158
Filing Date
2004-02-13
Accepted
2004-02-13 14:06:58
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P. ("BVF2")BIOTECHNOLOGY VALUE FUND, L.P. ("BVF")BVF INC. ("BVF INC.")BVF INVESTMENTS, L.L.C. ("INVESTMENTS")BVF PARTNERS L.P. ("PARTNERS")INVESTMENT 10, L.L.C. ("INVESTMENT 10")

Document Format Files

Seq Description Document Type Size
1 sc13ga.htm SC 13G/A 98291
  Complete submission text file 0000898432-04-000158.txt   100574
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address
Business Address PARC CLUB DU MOULIN A VENT 33 AVE DU DOCTEUR GEORGES LEVY VENISSIEUX CED I0 69693 2126641666
FLAMEL TECHNOLOGIES SA (Subject) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50223 | Film No.: 04597352
SIC: 2834 Pharmaceutical Preparations